Italy: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Italy

The Italian market for other medicaments for therapeutic or prophylactic uses was finally on the rise to reach $X in 2022, after two years of decline. In general, the total consumption indicated a buoyant expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Consumption of peaked in 2022 and is expected to retain growth in years to come.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Italy

In value terms, production of other medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2022 estimated in export price. Over the period under review, the total production indicated a buoyant increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, production attained the peak level and is likely to continue growth in the immediate term.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Italy

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after six years of decline. Overall, exports, however, saw a abrupt decrease. The most prominent rate of growth was recorded in 2021 with an increase of X%. The exports peaked at X tons in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses expanded sharply to $X in 2022. In general, exports showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2014 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X. From 2015 to 2022, the growth of the exports of remained at a lower figure.

Exports by Country

France (X tons), Spain (X tons) and Germany (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Italy, with a combined X% share of total exports. The Netherlands, Greece, the Czech Republic, Belgium, Poland, Canada, Portugal, South Korea and Australia lagged somewhat behind, together comprising a further X%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the Czech Republic (with a CAGR of X%), while the other leaders experienced mixed trend patterns.

In value terms, Germany ($X), France ($X) and Spain ($X) constituted the largest markets for other medicaments for therapeutic or prophylactic uses exported from Italy worldwide, with a combined X% share of total exports. The Netherlands, Greece, the Czech Republic, Belgium, Canada, Poland, Portugal, South Korea and Australia lagged somewhat behind, together comprising a further X%.

Among the main countries of destination, the Czech Republic, with a CAGR of X%, saw the highest growth rate of the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, which is down by X% against the previous year. Over the period under review, the export price, however, recorded a significant expansion. The most prominent rate of growth was recorded in 2017 an increase of X% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2020; however, from 2021 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Australia ($X per ton), while the average price for exports to Spain ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Australia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Italy

In 2022, purchases abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after three years of decline. Overall, imports enjoyed a resilient increase. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, imports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. Over the period under review, imports, however, showed a noticeable shrinkage. Over the period under review, imports of reached the peak figure at $X in 2016; however, from 2017 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, Austria (X tons) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Italy, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Austria exceeded the figures recorded by the second-largest supplier, Turkey (X tons), fourfold. France (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Austria amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Turkey (X% per year) and France (X% per year).

In value terms, the largest other medicaments for therapeutic or prophylactic uses suppliers to Italy were Belgium ($X), Switzerland ($X) and Germany ($X), together accounting for X% of total imports. Austria, Ireland, Spain, the Netherlands, China, India, France, Turkey, Denmark and the UK lagged somewhat behind, together comprising a further X%.

Turkey, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, which is down by X% against the previous year. In general, the import price saw a abrupt downturn. The pace of growth appeared the most rapid in 2019 when the average import price increased by X%. The import price peaked at $X per ton in 2014; however, from 2015 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Switzerland ($X per ton), while the price for Turkey ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Spain (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :